Duchenne muscular dystrophy trials in Belarus

1 trial · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 1/2Taking people
  A Study to Evaluate the Tolerability, Safety and Efficacy of GNR-097 Gene Therapy in Pediatric Patients With Duchenne Muscular Dystrophy

  Where

  Minsk

  Age

  4 years to 9 years

  People

  32 worldwide

  Run by

  AO GENERIUM

  See details and how to joinNCT07673809